THROMBOLYTIC THERAPY IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION
It is reported that the implementation in clinical practice thrombolytic (fibrinolytic) therapy resulted inmortality reduction during firstmonth after myocardial infarction from 17-18% to 5-8%. Different details of this therapy are considered: terms of thrombolysis since the beginning of myocardial...
Main Authors: | E. V. Konstantinova, A. V. Magnitskyi, N. A. Schostak |
---|---|
Format: | Article |
Language: | English |
Published: |
Столичная издательская компания
2016-01-01
|
Series: | Рациональная фармакотерапия в кардиологии |
Subjects: | |
Online Access: | https://www.rpcardio.online/jour/article/view/1054 |
Similar Items
-
Use of thrombolytic agents for ST-elevation myocardial infarction care in India: An expert consensus
by: Arun Chopra, et al.
Published: (2021-01-01) -
Alveolar Hemorrhage Following Thrombolytic Therapy for Acute Myocardial Infarction: Two Case Reports and Literature Review
by: Ben Mrad I, et al.
Published: (2021-08-01) -
Fibrinolytic Therapy in Thrombosis of Mechanical Valves: Outcomes and Complications
by: Ali Nasri Nasrabadi, et al.
Published: (2023-09-01) -
CLINICAL RESULTS OF THROMBOLYTIC THERAPY WITH ALTEPLASE AND TENECTEPLASE IN PATIENTS WITH MYOCARDIAL INFARCTION
by: L. A. Bondarenko, et al.
Published: (2015-12-01) -
Safety and efficacy of streptokinase, tenecteplase, and reteplase in patients diagnosed with ST-elevation myocardial infarction: A comparative study
by: Bhargavi Neela, et al.
Published: (2020-01-01)